IGF1R and breast cancer: The increase in HRGβ1-induced Akt phosphorylation observed following treatment of MCF-7 and T47D breast cancer cells with the IGF-IR/IR inhibitor ABDP for 24 hours was effectively blocked using siRNA specific to IRS-1 (Figure 6a).